LARANJEIRA CHARLES ANTHONY 4
4 · Pacira BioSciences, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
LARANJEIRA CHARLES ANTHONY
SVP, Technical Operations
Transactions
- Exercise/Conversion
Common Stock
2022-06-14$38.35/sh+6,000$230,100→ 41,752 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-06-14−6,000→ 9,000 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.